Date |
Product |
Disease |
Phase |
Company |
Therapeutic area |
2018-08-07
|
TG-1101 (ublituximab) |
multiple sclerosis |
3 |
TG Therapeutics (USA - NY) |
Autoimmune diseases - Neurodegenerative diseases |
2018-08-06
|
biomarker blood tumor mutational burden (bTMB) |
|
|
Foundation Medicine (USA - MA) Roche (Switzerland) |
Cancer - Oncology |
2018-08-02
|
remetinostat |
basal cell carcinoma |
2 |
Medivir (Sweden) |
Cancer - Oncology |
2018-08-01
|
ADVM-053 |
hereditary angioedema (HAE) |
preclinical |
Adverum Biotechnologies (USA - CA) |
Rare diseases - Genetic diseases - Hematological diseases |
2018-08-01
|
ADVM-043 |
alpha-1 antitrypsin (A1AT) deficiency |
1-2 |
Adverum Biotechnologies (USA - CA) |
Rare diseases - Genetic diseases |
2018-07-27
|
MIV-711 |
knee osteoarthritis |
2 |
Medivir (Sweden) |
Rheumatic diseases - Inflammatory diseases – Bone diseases |
2018-07-26
|
DTX401 |
glycogen storage disease type Ia (GSDIa) |
1-2 |
Ultragenyx Pharmaceutical (USA - CA) |
Rare diseases - Genetic diseases - Metabolic diseases |
2018-07-25
|
anti-Abeta antibody MABT5102A (crenezumab) |
mild to moderate Alzheimer's disease |
2 |
AC Immune (Switzerland) Genentech, a member of Roche Group (USA - Switzerland) |
Neurodegenerative diseases |
2018-07-24
|
CYAD-101 |
unresectable colorectal cancer |
1 |
Celyad (Belgium) |
Cancer - Oncology |
2018-07-24
|
doravirine (MK-1439) |
HIV-1 infection |
3 |
Merck&Co (USA - NJ) |
Infectious diseases |
2018-07-24
|
dolutegravir and lamivudine |
HIV-1 infection in adults |
3 |
ViiV Healthcare (UK - USA) |
Infectious diseases |
2018-07-24
|
pamiparib (BGB-290) |
advanced gastric cancer |
3 |
BeiGene (China) |
Cancer - Oncology |
2018-07-23
|
SB-318 (adeno-associated virus serotype 2/6 (rAAV2/6) vectors encoding zinc finger nucleases (ZFNs) and the human alpha-L-iduronidase (hIDUA) gene) |
mucopolysaccharidosis I (Hurler syndrome) |
1-2 |
Sangamo Therapeutics (USA - CA) |
Rare diseases - Genetic diseases |
2018-07-22
|
tislelizumab (BGB-A317) |
relapsed or refractory Hodgkin lymphoma |
2 |
BeiGene (China) |
Cancer - Oncology |
2018-07-19
|
ATOR-1015 |
|
1 |
Alligator Bioscience (Sweden) |
Cancer - Oncology |
2018-07-17
|
crenezumab |
Alzheimer's disease |
3 |
Roche (Switzerland) |
Neurodegenerative diseases |
2018-07-08
|
ART-I02 |
rheumatoid arthritis, osteoarthritis |
1b |
Arthrogen (The Netherlands) |
Autoimmune diseases – Inflammatory diseases - Rheumatic diseases |
2018-07-04
|
Cabometyx™ (cabozantinib) |
|
3 |
Exelixis (USA - CA) Ipsen (France) |
|
2018-07-04
|
Cabometyx™ (cabozantinib) |
|
3 |
Exelixis (USA - CA) Ipsen (France) |
|
2018-06-29
|
prurisol |
moderate-to-severe plaque psoriasis |
2b |
Innovation Pharmaceuticals (USA - MA) |
Autoimmune diseases - Dermatological diseases |